Dermata Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
339
across all filing types
Latest filing
2026-04-17
Annual Report
Country
US
United States of America
Listing
US
DRMA
Dermata Therapeutics is a medical dermatology company that has shifted its strategic focus to developing and commercializing scientifically-backed over-the-counter (OTC) pharmaceutical products. The company leverages its proprietary Spongilla technology, which combines natural elements with FDA-listed OTC ingredients to create differentiated skin care solutions. Its initial product is a once-weekly acne kit, supported by clinical validation from its Phase 3 START-1 trial. Dermata plans to expand its portfolio with product candidates for other common skin conditions, such as psoriasis and seborrheic dermatitis, aiming to provide patients with accessible and effective treatments to manage their skin health.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | |
| 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English | |
| 8-K - DERMATA THERAPEUTICS, INC. (0001853816) (Filer) | 2026-02-25 | English | |
| SCHEDULE 13G/A Filing | 2026-02-18 | English | |
| SCHEDULE 13G/A Filing | 2026-02-17 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 34662829 | ARS - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 34662700 | DEF 14A - Dermata Therapeutics, Inc. (0001853816) (Filer) | 2026-04-17 | English | ||
| 32968155 | 4 - Dermata Therapeutics, Inc. (0001853816) (Issuer) | 2026-03-17 | English | ||
| 32899840 | 8-K - DERMATA THERAPEUTICS, INC. (0001853816) (Filer) | 2026-02-25 | English | ||
| 32075223 | SCHEDULE 13G/A Filing | 2026-02-18 | English | ||
| 32075176 | SCHEDULE 13G/A Filing | 2026-02-17 | English | ||
| 18542004 | SCHEDULE 13G/A - Dermata Therapeutics, Inc. (0001853816) (Subject) | 2026-02-09 | English | ||
| 32075231 | 8-K Filing | 2026-02-03 | English | ||
| 32075139 | SCHEDULE 13D/A Filing | 2026-02-02 | English | ||
| 32075157 | 424B3 Filing | 2026-01-29 | English | ||
| 13422563 | 424B5 | 2026-01-27 | English | ||
| 32075201 | 8-K Filing | 2026-01-27 | English | ||
| 13422565 | S-3 | 2026-01-22 | English | ||
| 13422566 | Major Shareholding Notification 2026 | 2026-01-08 | English | ||
| 13422567 | Regulatory Filings 2026 | 2026-01-07 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Dermata Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35467/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35467 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35467 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35467 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35467}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Dermata Therapeutics, Inc. (id: 35467)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.